2. Characteristics of Studies.
STUDY | Yes or No | Agents | Months | Yes or No | Number | Liver Recurrence | Liver Recurrence |
Authors | Systemic Chemotherapy in Controls? | HAI Chemo | Duration HAI Chemo | Post Randomization Exclusions | Operative Mortality | HAI | Control |
Wagman | No | FUdR | 12 | No | 0 | 1 | NS |
Lygidakis | No | 5FU, Mit. C, Folinic Acid, gamma interferon, Carboplastin, Farmorubicin | 36 | No | 2 | 0 | 8 |
Lorenz | No | 5FU, Folinic Acid | 6 | Yes | 11 | 23 | 22 |
Rudroff | No | 5FU, Mit. C | 5 | No | 1 | 3 | 7 |
NKemeny | Yes | Floxuridine | 4.5 | No | 5 | 7 | 30 |
MKemeny | No | FUdR + Syst. 5FU | 4 HAI; 8 Systemic | Yes | 2 | 8 | 24 |
Tono | Yes | 5FU | 1.5 | No | 0 | 1 | 6 |